ALLOGENE THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Mar 2026)
What this means for you
Registered since 10 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88136820
- Registration number
- 5933530
- Mark type
- Design + words
- Filed
- 28 Sept 2018
- Published for opposition
- 26 Feb 2019
- Registered
- 10 Dec 2019
- Attorney of record
- Thomas L. Holt
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
Owner
- Allogene Therapeutics, Inc., South San Francisco, CA, US
- Allogene Therapeutics, Inc., South San Francisco, CA, US
- Allogene Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 04 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Mar 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Dec 2025 — TEAS SECTION 8 & 15 RECEIVED
- 28 Feb 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 28 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 28 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 07 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED